Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension study of bevacizumab in patients with solid tumours previously treated in Roche/Genentech bevacizumab trials
2011-002009-31Phase 4Completed
- Sponsor
- Roche
- Start
- Mar 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of bevacizumab in Nonhematologic neoplasms and cancer, sponsored by Roche. Primary endpoint: Safety data related to bevacizumab. Started Mar 2012; status: completed.
02
Drugs
bevacizumab
03
Conditions
Nonhematologic neoplasmscancer
Beyond the preview
Go deeper on 2011-002009-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002009-31.